The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(1R,5S)-11-(5-Amino-1-methyl-6-oxo-1,6-dihydropyridine-3-carbonyl)-2,3,5,6-tetrahydro-1,5-epiminobenzo[d]azocin-4(1H)-one ID: ALA5084439
PubChem CID: 166634168
Max Phase: Preclinical
Molecular Formula: C18H18N4O3
Molecular Weight: 338.37
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cc(C(=O)N2[C@H]3Cc4ccccc4[C@@H]2CNC3=O)cc(N)c1=O
Standard InChI: InChI=1S/C18H18N4O3/c1-21-9-11(6-13(19)18(21)25)17(24)22-14-7-10-4-2-3-5-12(10)15(22)8-20-16(14)23/h2-6,9,14-15H,7-8,19H2,1H3,(H,20,23)/t14-,15-/m0/s1
Standard InChI Key: KYNLKRBYUMMJKS-GJZGRUSLSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
-2.0638 1.3951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3492 1.8074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6373 1.3955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6373 0.5703 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3474 0.1585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0638 0.5666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0567 1.9761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7685 1.9761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3491 1.3955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3491 0.5703 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7685 -0.0103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0565 -0.0103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0638 1.8081 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.5113 1.0262 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0215 0.0830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8464 0.0600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6090 -0.6314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0214 -1.3464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6094 -2.0585 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2159 -2.0585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6279 -1.3481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2196 -0.6314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6286 -2.7731 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.9821 2.7731 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.7711 -0.4228 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.4530 -1.3481 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0220 -2.7731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 1 0
9 8 1 0
10 9 1 0
11 10 1 0
12 11 1 0
4 12 1 0
9 13 2 0
8 14 1 0
12 14 1 0
14 15 1 0
15 16 2 0
15 17 1 0
18 17 2 0
19 18 1 0
20 19 1 0
21 20 1 0
22 21 2 0
17 22 1 0
20 23 2 0
8 24 1 6
12 25 1 6
21 26 1 0
19 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 338.37Molecular Weight (Monoisotopic): 338.1379AlogP: 0.21#Rotatable Bonds: 1Polar Surface Area: 97.43Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.96CX Basic pKa: 0.34CX LogP: -0.81CX LogD: -0.81Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.78Np Likeness Score: -0.25
References 1. Winter-Holt JJ, Bardelle C, Chiarparin E, Dale IL, Davey PRJ, Davies NL, Denz C, Fillery SM, Guérot CM, Han F, Hughes SJ, Kulkarni M, Liu Z, Milbradt A, Moss TA, Niu H, Patel J, Rabow AA, Schimpl M, Shi J, Sun D, Yang D, Guichard S.. (2022) Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models., 65 (4.0): [PMID:35133824 ] [10.1021/acs.jmedchem.1c01871 ]